Strong and Weak Hydrogen Bonds in Protein–Ligand Recognition

Desiraju GR (2011) A bond by any other name. Angew Chem Int Ed Engl 35:52–59. https://doi.org/10.1002/anie.201002960

Desiraju GR, Steiner T (1999) The weak hydrogen bond in structural chemistry and biology. Oxford University Press, Oxford. https://doi.org/10.1093/acprof:oso/9780198509707.001.0001

Jeffrey GA, Saenger W (1991) Hydrogen bonding in biological structures. Springer, Berlin. https://doi.org/10.1007/978-3-642-85135-3

Desiraju GR (1995) Supramolecular synthons in crystal engineering—a new organic-synthesis. Angew Chem Int Ed 34:2311–2327. https://doi.org/10.1002/anie.199523111

Glusker JP (1998) Directional aspects of intermolecular interactions. In: Weber E (ed) Topics in current chemistry: design of organic solids. Springer, Berlin, pp 1–56. https://doi.org/10.1007/3-540-69178-2_1

Williams MA, Ladbury JE (2003) Hydrogen bonds in protein-ligand complexes. In: Böhm H-J, Schneider G (eds) Protein-ligand interactions: from molecular recognition to drug design. Wiley, Hoboken, pp 137–161. https://doi.org/10.1002/9783527610754.pl02

Sarkhel S, Desiraju GR (2004) N–H…O, O–H…O, and C–H…O Hydrogen bonds in protein–ligand complexes: strong and weak interactions in molecular recognition. Proteins 54:247–259. https://doi.org/10.1002/prot.10567

Williams DH, Stephens E, O’Brien DP, Zhou M (2004) Understanding noncovalent interactions: ligand binding energy and catalytic efficiency from ligand-induced reductions in motion within receptors and, enzymes. Angew Chem Int Ed 43:6596–6616. https://doi.org/10.1002/anie.200300644

Gandhi R, Pillai O, Thilagavathi R, Gopalakrishnan B, Kaul CL, Panchagnula R (2002) Characterisation of azithromycin hydrates. Eur J Pharm Sci 16:175–184. https://doi.org/10.1016/S0928-0987(02)00087-8

Connelly PR, Snyder PW, Zhang Y, McClain B, Quinn BP, Johnston S, Medek A, Tanoury J, Griffith J, Walters WP, Dokou E, Knezic D, Bransford P (2015) The potency–insolubility conundrum in pharmaceuticals: mechanism and solution for hepatitis C protease inhibitors. Biophys Chem 196:100–108. https://doi.org/10.1016/j.bpc.2014.08.008

Sanphui P, Rajput L, Gopi SP, Desiraju GR (2016) New multi-component solid forms of an anti-cancer drug erlotinib: role of auxiliary interactions in determining a preferred conformation. Acta Crystallogr Sect B 72:291–300. https://doi.org/10.1107/s2052520616003607

Desiraju GR (2002) Hydrogen bridges in crystal engineering: interactions without borders. Acc Chem Res 35:565–573. https://doi.org/10.1021/ar950135n

Sutor DJ (1962) The C-H…O hydrogen bond in crystals. Nature 195:68–69

Sutor DJ (1963) Evidence for the existence of C–H…O hydrogen bonds in crystals. J Chem Soc 1105–1110. https://doi.org/10.1039/jr9630001105

Taylor R, Kennard O (1982) Crystallographic evidence for the existence of C–H…O, C–H…N and C–H…Cl hydrogen bonds. J Am Chem Soc 104:5063–5070. https://doi.org/10.1021/ja00383a012

Extance A (2019) The forgotten female crystallographer who discovered C–H…O bonds. Chem World. https://www.chemistryworld.com/features/the-forgotten-female-crystallographer-who-discovered-cho-bonds/3010324.article

Horowitz S, Trievel R, Scheiner S, Schwalbe C (2019) Do you know about C–H…O? Chem World. https://www.chemistryworld.com/opinion/do-you-know-about-cho/3010705.article

Derewenda ZS, Lee L, Derewenda U (1995) The occurrence of C–H…O hydrogen bonds in proteins. J Mol Biol 252:248–262. https://doi.org/10.1006/jmbi.1995.0492

Wahl MC, Sundaralingam M (1997) C–H…O hydrogen bonding in biology. Trends Biochem Sci 22:97–102. https://doi.org/10.1016/s0968-0004(97)01004-9

Steiner T (1995) Water molecules which apparently accept no hydrogen bonds are systematically involved in C-H…O interactions. Acta Crystallogr Sect D 51:93–97. https://doi.org/10.1107/S0907444994007614

Yesselman JD, Horowitz S, Brooks CL III, Trievel RC (2015) Frequent side chain methyl carbon-oxygen hydrogen bonding in proteins revealed by computational and stereochemical analysis of neutron structures. Proteins 83:403–410. https://doi.org/10.1002/prot.24724

Castellano RK (2004) Progress toward understanding the nature and function of C-H…O interactions. Curr Org Chem 8:845–865. https://doi.org/10.2174/1385272043370384

Fabiola GF, Krishnaswamy S, Nagarajan V, Pattabhi V (1997) C–H…O hydrogen bonds in β-sheets. Acta Crystallogr D 53:316–320. https://doi.org/10.1107/S0907444997000383

Bhattacharyya R, Chakrabarti P (2003) Stereospecific interactions of proline residues in protein structures and complexes. J Mol Biol 331:925. https://doi.org/10.1016/s0022-2836(03)00759-9

Desiraju GR, Sharma CVKM (1991) C–H…O hydrogen-bonding and topochemistry in crystalline 3,5-dinitrocinnamic acid and its 1–1 donor-acceptor complex with 2,5-dimethoxycinnamic acid. J Chem Soc Chem Commun. https://doi.org/10.1039/c39910001239

Viswamitra MA, Radhakrishnan R, Bandekar J, Desiraju GR (1993) Evidence for O–H…C and N–H…C hydrogen-bonding in crystalline alkynes, alkenes, and aromatics. J Am Chem Soc 115:4868–4869. https://doi.org/10.1021/ja00064a055

Thallapally PK, Katz AK, Carrell HL, Desiraju GR (2002) Unusually long cooperative chain of seven hydrogen bonds. An alternative packing type for symmetrical phenols. Chem Commun. https://doi.org/10.1039/b110036j

Steiner T, Koellner G (2001) Hydrogen bonds with π-acceptors in proteins: frequencies and role in stabilizing local 3D structures. J Mol Biol 305:535–557. https://doi.org/10.1006/jmbi.2000.4301

Desiraju GR (2005) C-H…O and other weak hydrogen bonds. From crystal engineering to virtual screening. Chem Commun. https://doi.org/10.1039/b504372g

Panigrahi SK, Desiraju GR (2007) Strong and weak hydrogen bonds in the protein–ligand interface. Proteins 67:128–141. https://doi.org/10.1002/prot.21253

Lipinski CA, Lombardo F, Dominy BW, Feeney PL (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Del Rev 23:3–25. https://doi.org/10.1016/S0169-409X(96),00423-1

Pierce AC, Sandretto KL, Bemis GW (2002) Kinase inhibitors and the case for C–H…O hydrogen bonds in protein–ligand binding. Proteins 49:567–576. https://doi.org/10.1002/prot.10259

Adrian JC, Wilcox CS (1992) General effects of binding-site water exclusion on hydrogen-bond based molecular recognition systems—a closed binding-site is less affected by environmental-changes than an open site. J Am Chem Soc 114:1398. https://doi.org/10.1021/ja00030a040

Berkovitch-Yellin Z, Leiserowitz L (1984) The role played by C-H…O and C–H…N interactions in determining molecular packing and conformation. Acta Crystallogr Sect B 40:159–165. https://doi.org/10.1107/s0108768194012061

Anthony A, Jaskolski M, Nangia A, Desiraju GR (1998) Isostructurality in crystalline oxa-androgens: a case of C-H…O and C–H…O interaction mimicry and solid solution formation. Chem Commun. https://doi.org/10.1039/a806607h

Thakur TS, Azim Y, Srinu T, Desiraju GR (2010) N–H…O and C–H…O interaction mimicry in the 1:1 molecular complexes of 5,5-diethylbarbituric acid with urea and acetamide. Curr Sci 98:793–802

Quiocho FA (1996) Atomic basis of the exquisite specificity of phosphate and sulfate transport receptors. Kidney Int 49:943–946

Klaholz BP, Moras D (2002) C–H…O hydrogen bonds in the nuclear receptor RAR—a potential tool for drug selectivity. Structure 10:1197–1204. https://doi.org/10.1016/S0969-2126(02),00828-6

Jiang L, Lai L (2002) C–H…O hydrogen bonds at the protein–protein interfaces. J Biol Chem 277:37732–37740. https://doi.org/10.1074/jbc.M204514200

Aparna V, Rambabu G, Panigrahi SK, Sarma JARP, Desiraju GR (2005) Virtual screening of 4-anilinoquinazoline analogues as egfr kinase inhibitors: importance of hydrogen bonds in the evaluation of poses and scoring functions. J Chem Inf Model 45:725–738. https://doi.org/10.1021/ci049676u

Gopalakrishnan B, Aparna V, Jeevan J, Ravi M, Desiraju GR (2005) A virtual screening approach for thymidine monophosphate kinase inhibitors as antitubercular agents based on docking and pharmacophore models. J Chem Inf Model 45:1101–1108. https://doi.org/10.1021/ci050064z

Gruenberg S, Stubbs MT, Klebe G (2002) Successful virtual screening for novel inhibitors of human carbonic anhydrase: strategy and experimental confirmation. J Med Chem 45:3588–3602. https://doi.org/10.1021/jm011112j

Lyne PD (2002) Structure-based virtual screening: an overview. Drug Discov Today 7:1047–1055. https://doi.org/10.1016/s1359-6446(02)02483-2

Bleicher KH, Bohm H-J, Muller K, Alanine AI (2003) Hit and lead generation: beyond high-throughput screening. Nat Rev Drug Discovery 2:369–378. https://doi.org/10.1038/nrd1086

Stamos J, Silwkowski MX, Eigenbrot C (2002) Structure of the epidermal growth factor receptor kinase domain alone and in the complex with a 4-anilinoquinazoline inhibitor. J Biol Chem 48:46265–46272. https://doi.org/10.1074/jbc.M207135200

Auffinger P, Hays FA, Westhof E, Ho PS (2004) Halogen bonds in biological molecules. Proc Natl Acad Sci USA 101:16789–16794. https://doi.org/10.1073/pnas.0407607101

Shaw N, Cheng C, Tempel W, Chang J, Ng J, Wang X-Y, Perrett S, Rose J, Rao Z, Wang B-C, Liu Z-J (2007) (NZ)CH…O Contacts assist crystallization of a ParB-like nuclease. BMC Struct Biol 7:46. https://doi.org/10.1002/pro.420

Misra P, Chakrabarti R, Vikramadithyan RK, Gopalakrishnan B, Suresh J, Jagadheshan H, Cynthia G, Rajjak A, Kashireddy P, Yu S, Surapureddi S, Qi C, Zhu Y-J, Rao MS, Reddy JK, Rajagopalan R (2003) PAT5A: a partial agonist of peroxisome proliferator-activated receptor is a potent antidiabetic thiazolidinedione yet weakly adipogenic. J Pharm Exp Ther 306:763–771. https://doi.org/10.1124/jpet.103.049791

Arunan E, Desiraju GR, Klein RA, Sadlej J, Scheiner S, Alkorta I, Clary DC, Crabtree RH, Dannenberg JJ, Hobza P, Kjaergaard HG, Legon AC, Mennucci B, Nesbitt DJ (2011) Defining the hydrogen bond: an account (IUPAC technical report). Pure Appl Chem 83:1619–1636. https://doi.org/10.1351/PAC-REP-10-01-01